Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 1,477	$ (30,093)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation	9,581	6,055
Depreciation and amortization	5,232	5,241
Amortization of debt issuance costs and accretion of exit fees	0	341
Debt issuance costs on term loan expensed upon election of fair value option	0	453
Amortization of operating right-of-use assets	3,715	3,452
Loss on disposal of fixed assets	7	11
Change in fair value of common stock warrant liability	1,409	500
Change in fair value of redeemable convertible preferred stock warrant liability	176	49
Net gain on extinguishment of debt	0	(7,289)
Change in fair value of convertible notes	0	835
Change in fair value of term loan	3,505	1,650
Changes in operating assets and liabilities:
Accounts receivable	(9,937)	(13,741)
Inventories	(8,656)	(644)
Prepaid expenses and other current assets	(1,727)	(879)
Other non-current assets	(62)	(3,110)
Accounts payable	3,047	2,223
Accrued expenses and other current liabilities	3,972	882
Accrued commissions	166	642
Accrued compensation and employee benefits	5,268	3,306
Deferred revenue	(123)	(49)
Operating lease liabilities	(3,247)	(2,787)
Net cash provided by (used in) operating activities	13,803	(32,952)
Cash flows from investing activities:
Purchases of property and equipment	(7,344)	(3,328)
Net cash used in investing activities	(7,344)	(3,328)
Cash flows from financing activities:
Proceeds from issuance of debt, net	0	49,775
Repayment of debt upon extinguishment	0	(35,000)
Payment of exit fee and prepayment payable upon debt extinguishment	0	(1,688)
Principal payments on finance lease liabilities	(1,449)	(1,785)
Repurchase of common stock outstanding	0	(546)
Payment of debt issuance costs on term loan	0	(228)
Payment of deferred offering costs	(2,516)	0
Proceeds from exercise of stock options, net of repurchases	1,181	781
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs	0	129,996
Net cash (used in) provided by financing activities	(2,784)	141,305
Net increase in cash and cash equivalents	3,675	105,025
Cash and cash equivalents at beginning of period	191,477	97,268
Cash and cash equivalents at end of period	195,152	202,293
Supplemental cash flow disclosure:
Cash payments for interest	3,626	2,845
Cash paid for income taxes	460	9
Supplemental non-cash investing and financing activities:
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities	500	214
Issuance of Series C-1 redeemable convertible preferred stock upon settlement of convertible notes	0	39,886
Deferred offering costs in accounts payable and accrued expenses and other current liabilities	1,144	0
Cash paid for amounts included in the measurement of operating lease liabilities	6,594	6,374
Right-of-use assets obtained in exchange for new finance lease liabilities	0	214
Operating cash flows from financing leases (interest paid)	$ 89	$ 196